Creabilis Therapeutics Appoints Dr David Roblin as Chief Medical Officer
8/4/2011 10:53:51 AM
More...
|
Synexus Delivers Fast Phase II Study Patients for Creabilis Therapeutics
5/16/2011 10:00:40 AM
More...
|
Creabilis Therapeutics Appoints Dr. Eliot Forster as its New Chief Executive Officer
9/29/2010 6:32:52 AM
More...
|
Creabilis Appoints George F. Horner III as its Chairman
9/16/2010 12:52:23 PM
More...
|
Creabilis Therapeutics Appoints Anthony Wilson as New Chief Executive Officer
6/16/2008 11:18:13 AM
More...
|
Bioindustry Park Announces the Sudden Death of Silvano Fumero
1/9/2008 9:03:08 AM
More...
|
Nautilus Biotech And Creabilis Therapeutics Achieve Technical Milestone In Collaboration To Improve HMGB1 Box A For The Treatment Of Rage- And HMGB1-Related Pathologies
11/14/2006 10:41:43 AM
More...
|
Bio3 Research And Creabilis Therapeutics Sign Research Agreements With Cephalon, Inc. (CEPH)
12/8/2005 10:32:04 AM
More...
|
Bio3 Research And Creabilis Therapeutics Sign Research Agreements With Cephalon, Inc. (CEPH) Research Will Focus On Potential New Treatments For Psoriasis And Restenosis
12/1/2005 12:31:44 PM
More...
|
Nautilus Biotech And Creabilis Therapeutics Enter Collaboration Agreement On Novel Therapeutic Protein
10/19/2005 5:10:26 PM
More...
|